Qube Research & Technologies (QRT)
CHRS icon

Qube Research & Technologies (QRT)’s Coherus Oncology CHRS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-583,671
Closed -$1.94M – 4500
2023
Q4 		$1.94M Buy
+583,671
New +$1.56M ﹤0.01% 1545
2022
Q3 		– Sell
-86,551
Closed -$627K – 2550
2022
Q2 		$627K Buy
+86,551
New +$753K ﹤0.01% 1315
2022
Q1 		– Sell
-40,386
Closed -$645K – 2496
2021
Q4 		$645K Buy
+40,386
New +$706K 0.01% 1442
2020
Q3 		– Sell
-15,587
Closed -$278K – 1721
2020
Q2 		$278K Buy
15,587
+1,012
+7% +$17.1K ﹤0.01% 1333
2020
Q1 		$236K Buy
+14,575
New +$269K 0.01% 812

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CHRS Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Coherus Oncology (CHRS) in Q1 2024, closing a stake of 583,671 shares — an estimated $1.94M sold.

Qube Research & Technologies (QRT) first reported a position in CHRS in Q1 2020 and held it in 5 quarters. The position peaked at $1.94M in Q4 2023. 137 funds tracked by Wall St. Rank hold CHRS as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Coherus Oncology position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 583,671 Coherus Oncology shares in Q1 2024, an estimated $1.94M.
  • Qube Research & Technologies (QRT) first reported a position in Coherus Oncology in Q1 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Coherus Oncology position peaked at $1.94M in Q4 2023.
  • 137 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.